Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Caredx Inc (CDNA)

NASDAQ
Currency in USD
24.69
-1.23(-4.75%)
Closed
After Hours
24.690.00(0.00%)
CDNA Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
24.6526.24
52 wk Range
7.4234.84
Key Statistics
Edit
Prev. Close
25.92
Open
25.74
Day's Range
24.65-26.24
52 wk Range
7.42-34.84
Volume
789.1K
Average Vol. (3m)
823.82K
1-Year Change
167.77%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CDNA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
34.67
Upside
+40.42%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Show more

Caredx Inc Company Profile

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Compare CDNA to Peers and Sector

Metrics to compare
CDNA
Peers
Sector
Relationship
P/E Ratio
−9.3x−1.5x−0.7x
PEG Ratio
0.160.060.00
Price / Book
4.9x1.9x2.6x
Price / LTM Sales
4.3x74.2x3.2x
Upside (Analyst Target)
35.0%326.0%45.9%
Fair Value Upside
Unlock9.3%7.6%Unlock

Analysts' Recommendations

5 Buy
2 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 34.67

(+40.41% Upside)

People Also Watch

42.84
VCYT
-2.84%
168.92
NTRA
-2.92%
50.75
TWST
-3.20%
25.32
BEAM
-2.69%

FAQ

What Is the Caredx Inc (CDNA) Stock Price Today?

The Caredx Inc stock price today is 24.69

What Stock Exchange Does Caredx Inc Trade On?

Caredx Inc is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Caredx Inc?

The stock symbol for Caredx Inc is "CDNA."

What Is the Caredx Inc Market Cap?

As of today, Caredx Inc market cap is 1.32B.

What is Caredx Inc Earnings Per Share?

The Caredx Inc EPS is -2.73.

What Is the Next Caredx Inc Earnings Date?

Caredx Inc will release its next earnings report on Feb 26, 2025.

From a Technical Analysis Perspective, Is CDNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.